Is Ankylosing Spondylitis an Autoimmune Disease?

Yes, ankylosing spondylitis is an autoimmune disease. It develops when the immune system mistakenly targets healthy tissues in the sacroiliac joints, causing chronic inflammation, pain, and stiffness. While the exact cause is not known, the presence of the HLA-B27 gene plays an important role in its development.

Although managing ankylosing spondylitis can be challenging, with the right treatment, you can control the symptoms. At Total Orthopedics and Sports Medicine, we specialize in treating autoinflammatory diseases like ankylosing spondylitis. Our experienced team offers medication management and advanced imaging tests for early diagnosis. So, if you’re experiencing the symptoms of ankylosing spondylitis, reach out to us at 855-321-6784 for a free consultation!

What Makes Ankylosing Spondylitis an Autoimmune Condition?

Ankylosing Spondylitis is an autoimmune disease where the immune system mistakenly attacks the body’s own tissues. This leads to chronic inflammation, stiffness, and other complications in the spine, resulting in fused vertebrae. The condition is influenced by both genetic and environmental factors, with the HLA-B27 gene playing a significant role in the disease’s genetic predisposition.

The autoimmune response in AS occurs when the immune system cannot tell the difference between harmful invaders and the body’s own tissues. Mutations in the HLA-B27 gene are strongly associated with the disease severity. As a result, it increases the chances of the immune system attacking the spine and joints, leading to other inflammatory diseases. If untreated, this inflammation can also contribute to the development of rheumatoid arthritis.

Studies indicate that between 60% and 90% of individuals with axial spondyloarthritis carry the HLA-B27 allele. However, its presence alone does not ensure the development of the disease. The HLA-B27 gene accounts for less than 30% of the genetic contribution to ankylosing spondylitis, suggesting that other genetic and environmental factors are also involved in its onset. Further, research has identified that activation of the sXBP1/RARB/TNAP is a key factor in forming syndesmophytes that are characteristic of AS.

How Does Ankylosing Spondylitis Differ From Other Autoimmune Diseases?

Ankylosing spondylitis is different from other autoimmune diseases because it affects the spine and sacroiliac joints, leading to chronic inflammation and fusion of spinal bones. Unlike reactive arthritis and psoriatic arthritis, AS targets the axial skeleton and is associated with the HLA-B27 gene.

Moreover, AS starts in young adulthood (ages 15-45), whereas conditions like systemic autoimmune diseases (e.g., rheumatoid arthritis) appear later in life (ages 40-50). AS is unique in its involvement of the innate immune system, which plays a major role compared to other autoimmune diseases. T cell populations (γδ T cells) may contribute to the inflammatory process of AS. Furthermore, studies show that genes involved in antigen presentation (HLA-B27, ERAP1, ERAP2), Th17 responses, and macrophages are associated with AS.

Unlike many autoimmune diseases that rely on autoantibodies for diagnosis, Ankylosing Spondylitis does not involve autoantibodies. AS is often linked to extra-articular manifestations, such as inflammatory bowel disease and eye inflammation. In contrast, other autoimmune diseases may present a broader range of extra-articular effects. Additionally, the intestinal microbiota plays a role in the development of AS, connecting it to conditions like Crohn’s disease.

What Are the Symptoms of Ankylosing Spondylitis?

Ankylosing spondylitis causes chronic back pain and stiffness in the lower back and hips. Inflammation of the affected joints can limit flexibility and, over time, lead to spinal fusion. Moreover, initial symptoms may include neck pain, fatigue, and joint tenderness.

AS is a chronic inflammatory disorder where immune cells of the body attack the spinal cord and sacroiliac joints, leading to inflammation. Moreover, tumor necrosis factor (TNF) and other autoimmune components play a key role in increasing the severity of symptoms. As the disease progresses, radiographic changes can cause permanent damage. Along with back pain, AS may lead to inflammatory arthritis and pain in other joints. Over time, the disease can result in spinal fractures and a loss of biomechanical factors, affecting muscles, joints, and bones.

Therefore, you must get an early diagnosis from Total Orthopedics and Sports Medicine. After examining the patient’s pathophysiological factors, we offer prescription medications to reduce pain. We also use blood tests and magnetic resonance imaging to make accurate diagnoses. Get in touch now to prevent these types of systemic autoinflammatory diseases.

How Does Ankylosing Spondylitis Limit Your Movement?

Ankylosing spondylitis limits movement by causing inflammation in the spine and affected joints. This happens due to sentinel immune cells destroying the joint tissues in these areas. Over time, the inflammation can result in the fusion of spinal bones, reducing flexibility and restricting the ability to bend, twist, or perform everyday activities.

Moreover, ankylosing spondylitis leads to stiffness and pain, which increases due to mucosal-associated immune cells and innate-like immune cells that attack the body’s tissues. These immunological diseases decrease the body’s immune system by attacking its tissues, including the mast cells. So, as the disease progresses, the body’s immune system targets the ligaments attached to the spine. Also, in severe cases, joint replacement may become necessary. Another risk factor is the fusion of the vertebrae that leads to a forward-stooped posture, which hinders mobility.

Can Ankylosing Spondylitis Cause Other Inflammatory Conditions?

Yes, ankylosing spondylitis can trigger inflammation in other body parts, including the eyes, heart, and peripheral joints. This can result in conditions like uveitis, aortic valve inflammation, and psoriatic arthritis. It can also affect other joints beyond the spine and may lead to complications like lung scarring and heart problems.

Cell populations support the inflammatory response, and mucosal-associated invariant cells play a dominant role, characterized by the activity of innate-like immune cells in these processes. This immune misdirection increases the risk of related diseases and other symptoms. While the AS unknown aetiology is still under study, researchers also focus on the clonal expansion of lymphoid cells to understand how the immune system triggers the disease.

Therefore, managing ankylosing spondylitis requires early intervention to reduce inflammation and prevent long-term complications. At Total Orthopedics and Sports Medicine, our team of specialists offers personalized care to manage AS and prevent its progression to other complications. We have an engineering research center to stay on top of the latest advances in spinal osteotomy and other treatments to improve life expectancy.

How Do NSAIDs and Biologics Help Manage Autoimmune Conditions?

NSAIDs and biologics are essential in managing ankylosing spondylitis by reducing inflammation and alleviating pain. NSAIDs work by blocking inflammation-causing enzymes, which helps to relieve pain and stiffness. On the other hand, biologics target specific immune system molecules, preventing joint damage and slowing disease progression.

NSAIDs are the first line of defense against AS. They provide quick relief from pain and inflammation, helping patients maintain mobility. However, prolonged use of NSAIDs can lead to gastrointestinal problems. If NSAIDs do not effectively control the disease, biologics such as TNF inhibitors are introduced. These medications focus on specific immune pathways, providing long-term control of the disease and reducing spinal damage. Moreover, biologics help in managing the rheumatic disease symptoms associated with AS.

A systematic review found that both traditional NSAIDs and COX-2 selective inhibitors are effective in treating axial spondyloarthritis. COX-2 inhibitors provide better pain relief and improved function compared to a placebo. Research also shows that TNF inhibitors, such as infliximab, significantly enhance disease activity and quality of life for AS patients. Additionally, a meta-analysis suggests that bimekizumab, an IL-17A/F inhibitor, could be a promising future treatment option for AS.

Can Diet and Nutrition Help You Manage Ankylosing Spondylitis?

Yes, a diet rich in anti-inflammatory foods, like omega-3 fatty acids and antioxidants, can help manage ankylosing spondylitis. A balanced diet can reduce inflammation, improve joint function, and support overall health. Moreover, maintaining a healthy weight also alleviates stress on the spine and joints.

Excess weight adds extra pressure on the spine and joints, worsening pain and stiffness. A Mediterranean diet, rich in vegetables, fruits, whole grains, and healthy fats, can help lessen the severity of symptoms associated with AS, according to Arthritis Rheumatol. Fatty fish, walnuts, and flaxseeds, which are high in omega-3s, have anti-inflammatory effects. Moreover, antioxidant-rich fruits and vegetables help reduce inflammation by fighting oxidative stress.

Besides these, anti-noggin antibodies can help manage AS symptoms by targeting specific inflammatory pathways. So, if you develop ankylosing spondylitis and need personalized guidance, contact Total Orthopedics and Sports Medicine. Our expert team can help you create a comprehensive treatment plan that includes nutrition and other lifestyle factors.

What Are the Risks of Untreated Ankylosing Spondylitis?

Untreated Ankylosing Spondylitis (AS) can lead to serious complications, including permanent spinal fusion, reduced mobility, and chronic pain. The condition may also impact other organs, such as the eyes and lungs, and raise the risk of developing osteoporosis. Without prompt treatment, AS can cause irreversible joint damage, limiting flexibility and making it challenging to carry out everyday activities.

Besides this, untreated AS can also result in cardiovascular problems, including aortic valve inflammation. Therefore, getting early intervention and following a treatment plan can help manage the symptoms and slow disease progression, reducing long-term risks.

Total Orthopedics & Sports Medicine Offers Customized Treatment Plans For Autoimmune Spine Disorders — Book Your Visit Now!

Ankylosing Spondylitis is a type of human autoimmune disease that can severely impact daily life by causing pain, stiffness, and reduced flexibility in the spine. As the condition advances, inflammation may lead to the fusion of spinal bones, restricting movement and potentially causing poor posture. Additionally, AS increases the risk of complications such as uveitis and heart problems, further complicating its management.

At Total Orthopedics & Sports Medicine, we understand the increased risk of autoimmune spine disorders like AS. Therefore, our team provides advanced treatment plans according to your needs. With our expertise, we aim to reduce pain, improve mobility, and help you regain control over your daily activities. Book your visit today at our office at 1789 Sheepshead Bay Rd, Brooklyn, NY 11235, or call us at 855-321-6784. Let us help you manage your ankylosing spondylitis symptoms and other systemic autoimmune diseases.

FAQs